The innate immune system functions as a defensive front line against pathogenic invasion, but the proinflammatory products of activated monocytes and macrophages (e.g., TNF and NO) can also injure normal cells. Anti-inflammatory mediators restrain the innate immune response and prevent excessive collateral tissue damage. Spermine, a ubiquitous biogenic polyamine, specifically and reversibly suppresses the synthesis of monocyte proinflammatory cytokines. This may provide a counterregulatory mechanism to restrain monocyte activation in injured or infected tissues and in tumors where spermine levels are significantly increased. Here we show that monocyte spermine uptake was signifi-
Introduction
Monocytes and macrophages occupy a critical role in the orchestration of a competent innate immune response. When activated by pathogenic stimuli or injury, macrophages release tumor necrosis factor (TNF), other cytokines, and nitric oxide (NO) that bolster defense against invasion. NO, for instance, is cytotoxic to invading organisms, and increases regional blood flow to the affected tissues (1) , while TNF and interleukin-1 (IL-1) activate endothelial cells, recruit cantly increased following lipopolysaccharide stimulation. The polyamine analogue 1,4-bis(3-aminopropyl)-piperazine (BAP) inhibited LPS-stimulated monocyte spermine uptake via the "nonselective" polyamine transporter. BAP fully restored macrophage TNF synthesis despite the presence of spermine, indicating that the mechanism of monocyte deactivation by spermine is dependent on spermine uptake. Administration of BAP in vivo significantly augmented the development of carrageenan-induced paw edema and nitric oxide release. Thus, endogenous spermine normally inhibits the innate inflammatory response by restraining macrophages.
leukocytes, enhance procoagulant activity, and facilitate tissue remodeling (2, 3) . The importance of these responses is revealed by studies of TNF receptor knock-out mice, which are exquisitely sensitive to infection by intracellular pathogens, reflecting the normal role of TNF to enhance host defenses against infection (4) . These beneficial effects, however, are critically dependent on the magnitude of the immune response, because larger amounts of host-derived cytotoxins cause collateral damage to normal tissues (3, 5, 6) . Moreover, when release is sufficient to cause systemic exposure, macrophage-derived cytotoxins mediate lethal shock and tissue injury (7) . To prevent these potentially lethal effects, the immune system has evolved a series of counter-596 Molecular Medicine, Volume 5, Number 9, September 1999 regulatory mechanisms that inhibit macrophage activation. For example, anti-inflammatory cytokines (IL-10) and TGF-,B) and glucocorticoid hormones are released during inflammation and inhibit macrophage release of TNF and NO (8) (9) (10) (11) (12) (13) . Ultimately, therefore, successful resolution of pathogenic invasion depends on the beneficial activities of macrophage products within the context of a closely regulated macrophage response.
Spermine, a ubiquitous biogenic polyamine, is one of the most abundant molecules in eukaryotes. Proliferating cells and tissues generally have higher levels of polyamines, and injured cells release spermine into the extracellular milieu. Spermine levels increase significantly at sites of infection and injury (14) as well as in tumors (1 5) . More than 40 years ago, Hirsch and Dubois discovered that local accumulation of spermine in infected tissues can curb the growth of mycobacteria (16) . More recently, we found that spermine is a specific and reversible inhibitor of monocyte activation that suppresses the synthesis of TNF and other proinflammatory cytokines by human peripheral blood mononuclear cells. Spermine suppresses proinflammatory cytokine synthesis via a post-transcriptional mechanism (17) . Direct application of spermine together with carrageenan, an activator of the innate immune response, attenuates the development of carrageenan-induced inflammation, suggesting that macrophages are sensitive to spermine inhibition in vivo. In agreement with this mechanism, macrophages derived from polyamine-depleted mice (after treatment with a polyamine biosynthesis inhibitor, DMFMOme) release more TNF and IL-I in response to lipopolysaccharide (LPS) challenge (18) . On the basis of these and other results, we reasoned that the macrophage deactivating activity of spermine might be a critical mechanism to restrain macrophages from causing excessive collateral damage. Increased spermine levels at sites of tissue injury would "inform" macrophages that extensive tissue injury had occurred, and curb their further inflammatory activity.
Polyamine transport systems in mammalian cells have been divided functionally into two classes that are distinguished by differential affinity for terminal aminobutyl or aminopropyl groups (19) . One transporter class, termed "nonselective," facilitates the uptake of spermine, spermidine, and putrescine; the other class is specific for polyamines with aminopropyl groups (spermine and spermidine) but has a low affinity for putrescine. Cells alter the activity of the polyamine uptake systems to regulate intracellular polyamine availability (20) . Whereas active polyamine transport has been demonstrated in macrophages (21), a role for macrophage polyamine transport activity in modulating inflammatory responses has not been described previously.
We now report that human monocytes express a nonselective polyamine transporter, and that LPS stimulation significantly increased monocyte uptake of spermine via this transporter. When spermine accumulation via this transport system was inhibited by treatment with the polyamine analogue 1,4-bis(3-aminopropyl)-piperazine (BAP), mornocytes were not deactivated, and their proinflammatory activity was unrestrained despite the presence of elevated extracellular spermine. Application of BAP with carageenan in vivo significantly increased carrageenan-induced local inflammatory responses, indicating that monocytes incorporate endogenous spermine as a normal counterregulatory mechanism to restrain the magnitude of the innate immune response. 
Materials and Methods

Cell
Cytokine Assay
To stimulate cytokine production from human monocytes, freshly sonicated LPS was added to a final concentration of 100 ng/ml. To evaluate the effect of BAP on the inhibitory activity of spermine on monocyte TNF synthesis, human monocytes were preincubated with the concentration of BAP indicated for min and 35 ,uM of spermine (Sigma) for another min, then stimulated with 100 ng/ml of LPS. After 4 hr of LPS stimulation, supernatants were harvested for cytokine assay. TNF levels in the supernatants were determined by ELISA. Briefly, serial dilution of recombinant human TNF was used to generate standard curves. The 96-well microtiter plates coated with monoclonal anti-TNF antibodies were incubated with 60 ,ul of standards or supernatant samples for 2 hr at room temperature or overnight at 4°C. After washing with buffer containing 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, and 0.05% Tween-20, 60 pl of polyclonal anti-TNF antibodies diluted (1:200) in dilution buffer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.2% Tween-20, and 1% goat serum) was added and incubated at room temperature for 2 hr. Following several washes to remove the unbound antibodies, the bound antibodies were reacted for 30 min with alkaline phosphatase-conjugated goat anti-rabbit IgG (H+L) (Boehringer Mannheim, Indianapolis, IN) diluted 1:2500 in dilution buffer. After washing, the amounts of bound second antibodies were then determined by assaying for alkaline phosphatase activity with 100 gl of freshly prepared p-nitrophenylphosphate in diethanolamine buffer (10 mM diethanolamine and 0.5 mM MgCl, pH 9.5). After 30 min incubation at room temperature, the absorption at 405 nm was determined using a microtitre plate reader for TNF levels.
Carrageenan-Induced Footpad Inflammation Paw edema was induced by injecting 100 ,lI of 0.2% A-carrageenan (Sigma) in PBS, pH 7.4, into the plantar surface of the left hindpaw of male Lewis rats (300-350 g). Spermine and/or BAP at the concentrations indicated were coadministrated with carrageenan. The right hindpaw was injected with 100 ,l of PBS as a control. The thickness of the carrageenan-treated and PBStreated hindpaw was measured with calipers at the time points indicated, and the difference was used as an index of inflammation. To recover edema fluid from rat paws, rats were sacrificed [16] [17] [18] [19] [20] [21] [22] [23] [24] hr after carrageenan administration. Paws were excised at the level of the calcaneus bone, and placed in a 6-ml Falcon 2063 tube (a 4-to 4.5-mm hole was made with the cut side down). The 6-ml Falcon tube was then placed in a 15-ml Falcon 2097 conical tube with 50 p1l of PBS and centrifuged at 250-300 x g for 20 min and the resultant fluid was recovered for assay as described.
Determination of NO Production in Rat Paw NO production in the edema fluid from each paw was determined by measuring nitrite/nitrate level with a nonenzymatic NO assay kit (OXIS, Portland, OR). Serial dilution of nitrite was used to generate standard curves. Briefly, 40 Al of sample was adjusted to 190 pl with water, and then 10 pl1 of 30% ZnSO4 was added for protein precipitation. After 15 min incubation at room temperature, the samples were centrifuged at 4000 rpm for 5 min, and the supernatants as well as serially diluted NO standards were transferred to microcentrifuge tubes containing 0.5 g cadmium beads (sequentially prewashed with H20, 0.1 M HCI, and 0.1 M NH40H, pH 9.6) and incubated at room temperature overnight with agitation to convert nitrate to nitrite. After 5 min centrifugation at 4000 rpm, 60 pl1 of supernatant was added to wells in duplicate in a 96-well plate and adjusted to 100 pl with water. Greiss reagent (100 p,l) was then added to each well and incubated for 5 min at room temperature. The nitrite level in each edema fluid was determined by reading the absorbance at 570 nm in a microtiter plate reader, and the total NO level of each paw Spermine concentration (gM) was calculated as X (nmol/paw) = nitrite/nitrate in the sample (nmol/ml) x paw edema volume (ml). (Fig. 3) ; we also observed no significant effect of BAP on the magnitude of LPS-induced TNF release (not shown). BAP treatment, however, fully restored TNF synthesis in spermine-suppressed monocytes and the 50% effective concentration that restored TNF release in spermine treated cultures (EC50 = 8 ± 3 ,uM) was comparable to the IC50 of BAP as an inhibitor of spermine uptake (Fig. 3) . The TNF-enhancing activity of BAP in the presence of spermine was significantly correlated with the inhibitory activity of BAP against monocyte spermine uptake (correlation coefficient = 0.99; p < 0.05). Putrescine shares the nonselective polyamine transporter with spermine but does not exert an inhibitory activity on monocyte cytokine synthesis (17) . Given the requirement of spermine uptake for its inhibitory activity on monocyte TNF production, we reasoned that putrescine might also enhance cytokine production in spermine-suppressed human monocytes by competitively inhibiting the uptake of spermine. We therefore measured TNF release of sperminetreated human monocytes in the presence or absence of putrescine and observed a significant increase of TNF release by putrescine treatment in spermine-suppressed monocytes (not shown). Thus, with respect to inhibition of macrophage activation, spermine uptake is required for spermine inhibitory activity and increased spermine uptake in activated monocytes is a mechanism that acts to prevent monocyte overactivation.
Inhibition of Spermine Uptake Enhances Carrageenan-Induced Inflammation In Vivo
It has been well documented that spermine levels are increased in various inflammatory states including infection (16, 22, 23) , tissue injury (14, 24, 25) , and cancer (15, 26) , suggesting a role of endogenous spermine in regulating the inflammatory process. We recently demonstrated that direct application of exogenous spermine into animal footpad suppresses carrageenan-induced paw edema (17) , an inflammatory response that is predominantly mediated by macrophage products (e.g., TNF and NO) (27) (28) (29) whether endogenous spermine normally participates in the control of inflammatory responses. Accordingly, we evaluated the effects of BAP in carrageenan-induced paw edema by subcutaneous injection of BAP and carrageenan. Administration of BAP alone into rat foot pads failed to stimulate the development of edema in the absence of carrageenan, but coadministration of BAP with carrageenan significantly augmented carrageenan-induced foot pad inflamed (Fig. 4a) . We also measured the levels of NO (total nitrite/ nitrates) in the inflammatory paws and observed a significant increase of NO production in BAPtreated paws as compared with the controls (Fig. 4b) . The direct involvement of spermine in BAP-enhanced excessive inflammation was supported by the observation that BAP treatment fully "restores" exogenous spermine-suppressed inflammatory responses, whereas additional exogenous spermine significantly reduced inflammation (Fig. 4c ) typical of BAP treatment (Fig. 4a) . Taken together, these results indicate that endogenous spermine can be incorporated into macrophages to restrain the innate inflammatory response.
Discussion
Four distinct lines of evidence from the present study indicate that human monocytes might use a single nonselective transporter for the uptake of spermine. First, Eadie-Hofstee plot analysis of spermine uptake was linear, suggesting the presence of a single spermine transporter in human monocytes. Second, spermine treatment inhibits the uptake of putrescine and spermidine, indicating that the transporter for spermine is shared by putrescine and spermidine in human monocytes. This is further supported by the observation that putrescine effectively blocks the uptake-dependent effect of spermine on monocyte cytokine synthesis. Third, a similar time course for LPS-stimulated monocyte uptake of spermine, spermidine, and putrescine was observed, suggesting that LPS-stimulated uptake of polyamines is due to the enhancement of a nonselective transporter activity. The fourth line of evidence is the inhibition of polyamine uptake by the piperazine-like spermine homologue BAP. BAP inhibited the uptake of all three polyamines by a similar magnitude but had no effect on the uptake of structurally unrelated molecules glutamine and aspartic acid. Thus, BAP is a specific inhibitor of the nonselective transporter in human monocytes. It has been well documented that polyamine transport is an integral part of the system that regulates intracellular polyamine levels according to various needs (20) .
A role for monocyte polyamine transport activity, however, has not been previously re- Vehicle PBS was injected into the right hind footpad as control. Footpad thickness was measured [16] [17] [18] [19] [20] [21] [22] [23] [24] hr later, and the edema fluid was recovered. The difference (in mm) between the thickness of left and right hind footpad was defined as the inflammation
ported. An interesting observation in the present study is that monocyte spermine uptake is significantly increased following LPS stimulation. Inhibition of LPS-stimulated spermine uptake by BAP blocks the inhibitory activity of spermine on monocyte TNF production, and it displays a correlation coefficient of 0.99 (p < 0.05) between the inhibitory activity of BAP on spermine uptake and the enhancing activity of BAP on monocyte TNF production. Thus, spermine uptake is required for spermine suppression of monocyte cytokine synthesis, and increased spermine uptake in activated monocytes provides a mechanism to prevent excessive monocyte activation. In agreement with the critical role of spermine in the regulation of monocyte activation, increased spermine uptake in activated monocytes is reversible and time dependent. Thus, monocytes can recover their activity in subsequent inflammatory responses when spermine is reduced or inactivated. The activation of macrophages is a key event for the initiation and propagation of the innate inflammatory response. In the past, a number of molecules including IL-10, transforming growth factor beta (TGF-,3), and glucocorticoids have each been implicated in preventing excessive macrophage activation and inflammation (8) (9) (10) (11) (12) (13) . Unlike IL-10, TGF-J3, or the glucocorticoids, however, spermine is unique in being released locally from dying and injured cells (24) . The quantity of spermine released at inflammatory sites will not only reflect the severity of ongoing tissue damage but also proportionally attenuate the innate inflammatory response (Fig. 5 ). This provides a critical restraining influence on inflammation, as the monocyte-deactivating effects of spermine prevent further release of TNF and NO, thereby limiting the extent of inflammation and associated collateral damage. In agreement with this proposed mechanism, mucosal polyamine deficiency has been implicated in the pathogenesis of inflammatory bowel disease (30) .
Some 40 years ago, Hirsch and Dubos discovered increased local spermine levels at the site of mycobacteria infection (16) . Subsequent studies in humans and animals indicate that spermine level is also increased in trauma (14, 24, 25) , cancer (15, 26) , and other infections (22, 23 interesting that the innate immune response is generally defective in these inflammatory conditions (31) (32) (33) . Considering the anti-inflammatory activity of endogenous spermine, it is reasonable to consider that spermine accumulation in macrophages and monocytes may contribute to this immune dysfunction. It will be interesting to test whether the blockade of spermine activity with spermine antagonists like BAP can restore the innate immune response in these conditions. The data presented in this work indicate that cellular uptake of spermine is required for the inhibitory effect of spermine on monocyte cytokine synthesis. Recent evidence (34) indicates that fetuin, a negative acute-phase protein, is required for spermine inhibition on monocyte cytokine synthesis, because anti-fetuin antibodies prevent the cytokine-inhibiting effects of spermine. The relation between fetuin and the monocyte uptake of spermine is unknown. Immunoelectron microscopic studies (35) have revealed that intracellular spermine is predominately located on ribosomes of the rough endoplasmic reticulum, and it is one of the components of biologically active ribosomes. It is therefore possible that spermine might suppress monocyte cytokine synthesis by regulating monocyte cytokine mRNA translation or mRNA stabilization. In agreement with this, our previous studies (17) show that spermine suppresses 
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monocyte cytokine synthesis through a posttranscriptional mechanism. As mRNA translocation from nucleus to cytoplasm is another posttranscriptional control step of gene expression, it will be interesting also to address whether spermine regulates the nuclear export of cytokine transcripts. In summary, the present findings demonstrate that monocyte spermine transport can be significantly increased by inflammatory stimuli such as LPS and this transport is critical for the inhibitory activity of spermine on monocyte cytokine synthesis. Endogenous spermine at inflammatory sites normally participates in the control of the innate inflammatory response by deactivating macrophages. This macrophage-deactivating activity of spermine may play an important role in the prevention of excessive inflammation and inflammatory damage.
